Abstract. We have explored the composition and stability properties of individual microtubules (MTs) in the axons of cultured sympathetic neurons. Using morphometric means to quantify the MT mass remaining in axons after various times in 2 #g/ml nocodazole, we observed that ~48% of the MT mass in the axon is labile, depolymerizing with a t1/2 of "-,5 min, whereas the remaining 52% of the MT mass is stable, depolymerizing with a tt/2 of r~ 240 min. Immunofluorescence analyses show that the labile MTs in the axon are rich in tyrosinated ot-tubulin, whereas the stable MTs contain little or no tyrosinated ot-tubulin and are instead rich in posttranslationally detyrosinated and acetylated o~-tubulin. These results were confirmed quantitatively by immunoelectron microscopic analyses of the distribution of tyrosinated ot-tubulin among axonal MTs. Individual MT profiles were typically either uniformly labeled for tyrosinated ot-tubulin all along their length, or were completely unlabeled. Roughly 48% of the MT mass was tyrosinated, ~52% was detyrosinated, and ~85% of the tyrosinated MTs were depleted within 15 min of nocodazole treatment. Thus, the proportion of MT profiles that were either tyrosinated or detyrosinated corresponded precisely with the proportion of MTs that were either labile or stable respectively. We also observed. MT profiles that were densely labeled for tyrosinated a-tubulin at one end but completely unlabeled at the other end. In all of these latter cases, the tyrosinated, and therefore labile domain, was situated at the plus end of the MT, whereas the detyrosinated, and therefore stable domain was situated at the minus end of the MT, and in each case there was an abrupt transition between the two domains. Based on the frequency with which these latter MT profiles were observed, we estimate that minimally 40% of the MTs in the axon are composite, consisting of a stable detyrosinated domain in direct continuity with a labile tyrosinated domain. The extreme drug sensitivity of the labile domains suggests that they are very dynamic, turning over rapidly within the axon. The direct continuity between the labile and stable domains indicates that labile MTs assemble directly from stable MTs. We propose that stable MTs act as MT nucleating structures that spatially regulate MT dynamics in the axon.
M
ICROTUBULES (MTs) ~ are actively involved in the growth and maintenanceof the axon. This was initially inferred from ultrastructural studies of MT organization in growing axons (Yamada et al., 1971; Peters et al., 1974) ~ and from pharmacologic studies demonstrating that anti-MT drugs inhibit the growth of axons and can cause their retraction (Yamada et al., 1970; Daniels, 1973) . Since these initial observations were made, considerable effort has been devoted toward defining in molecular terms the mechanisms by which MT assembly and organization are regulated in the axon (for reviews, see Lasek, 1988; Meininger and Binet, 1989; Diaz-Nido et al., 1990) .
To date, most information on MT assembly and organization derives from in vitro studies on isolated MT proteins, or from studies on nonneuronal cells. These studies have established that MTs are assembled from tubulin subunits, and are intrinsically polar in their assembly kinetics (for review, MT, microtubule. see Dustin, 1984) . One end of the MT is favored for assembly over the other (for review, see Binder et al., 1975) , and these two ends of the MT are referred to as the "plus" and "minus" end respectively (Bergen and Borisy, 1980) . In the test tube, MT assembly can occur de novo by self-association of free sub/mits, but preferentially occurs by elongation from a MT template or nucleating structure (for review, see Kirschner, 1978) . Studies on MT assembly in intact cells indicate that self-association is strongly suppressed in favor of nucleated assembly, and that MT nucleation is spatially regulated by discrete nucleating structures such as the centrosome (for review, see Brinkley, 1985) . The minus ends of the MTs are directly associated with the nucleating structure, while the plus ends radiate away from the nucleating structure (Haimo et al., 1979; Heidemann and Mclntosh, 1980; Euteneuer and McIntosh, 1981) . Thus, a hallmark feature of MT nucleating structures is that they generate MT arrays of uniform polarity orientation.
Abbreviation used in this paper:
It is now well established that MTs in the axon also have a uniform polarity orientation; the plus ends of the MTs are directed away from the cell body toward the axon tip (Heidemann et al., 1981; Burton and Paige, 1981; Baas et al., 1987 Baas et al., , 1988 . Because axonal MTs are dynamic polymers, undergoing assembly and disassembly locally within the axon (Morris and Lasek, 1984; Okabe and Hirokawa, 1988; Black et al., 1989) , mechanisms must exist within the axon to organize local MT dynamics so that uniform polarity orientation is maintained. This conclusion is reinforced by the observation that the uniform polarity orientation of axonal MTs is recapitulated after recovery from episodes of MT depolymerization (Heidemann et al., 1984; Baas et al., 1987) . Thus, it is likely that nucleating structures organize MT dynamics locally in the axon. However, axons lack traditional MT nucleating structures such as the centrosome (Lyser, 1968; Sharp et al., 1982; Stevens et al., 1988; Okabe and Hirokawa, 1988) , and there is no structural evidence of specializations at the minus ends of axonal MTs which could serve as nucleating structures (Chalfie and Thompson, 1979; Bray and Bunge, 1981; Tsukita and Ishikawa, 1981) . What are the structures that serve as templates for local MT dynamics in the axon? It has been hypothesized by several authors that a unique class of especially stable MTs may act as the nucleating structures for MT dynamics in the axon (Brady et al., 1984; Morris and Lasek, 1984; Black et al., 1984; Heidemann et al., 1984; Baas and Heidemann, 1986) . A key prediction of this model is that individual MTs in the axon will consist of a stable domain in direct continuity with a newly assembled domain. The newly assembled domain is presumably more labile than the stable domain in that MT stabilization is thought to occur only after a temporal delay after MT assembly (Kirschner and Mitchison, 1986; Khawaja et al., 1988) . In support of the view that axonal MTs consist of stable and labile domains, stable and labile MTs have been identified in the axon (Brady et al., 1984; Lasek, 1982, 1984; Black et al., 1984 Black et al., , 1989 , and it has been shown that the MTs remaining in the axon after episodes of MT depolymerization are generally shorter than the MTs present in the unperturbed axon (Baas and Heidemann, 1986; Joshi et al., 1986; Sahenk and Brady, 1987) . However, to date, no evidence has been provided which directly demonstrates continuity between stable and labile MTs in the axon.
Here, we document a compositional difference between stable and labile MTs in the axon that permits us for the first time to simultaneously visualize and distinguish them at the electron microscopic level, and hence directly determine their spatial relationship relative to one another. In many types of MT arrays, posttranslational detyrosination occurs on a portion of the ot-tubulin after its incorporation into MTs , such that the more recently assembled, labile MTs are rich in the tyrosinated form of a-tubulin, whereas the older, more stable MTs are rich in the detyrosihated form Schulze et al., 1987; Kreis, 1987; Webster et al., 1987; Wheland and Weber, 1987; Gunderson et al., 1987; Bulinski et al., 1988) . Our data indicate that this is also the case in the axon. Labile MTs label with the mAb YL 1/2, which recognizes the tyrosinated but not the detyrosinated form of tx-tubulin (Kilmartin et al., 1982; Wheland et al., 1983) , whereas stable MTs do not label with this antibody. Using YL 1/2 in immunoelectron microscopic analyses, we demonstrate direct continuity between stable and labile MTs in the axon. Thus, individual MTs in the axon consist of distinct stable and labile domains.
Materials and Methods

Cell Culture
Rat sympathetic neurons were grown either as dissociated cultures or as explant cultures. For dissociated cultures, superior cervical ganglia were dissected from 1-5-d rat pups, treated with 0.25 mg/ml collagenase for 1 h followed by 0.25 mg/ml trypsin for 45 rain, and then triturated with a Pasteur pipette into a single cell dispersion. The neurons were then plated onto collagen-coated 35-ram tissue culture dishes in N2 medium (Moya et al., 1980) supplemented with 2.5% FCS, 5% human placental serum, 50 ng/ml nerve growth factor, and 0.6% methyl cellulose. Cultures were fed the following morning with the same medium without the methyl cellulose, but containing 5 t~M cytosine arabinoside to reduce nonneuronal contamination. After 10-14 d in culture, the neurons were transplanted to glass chamber slides that had been coated with polyethylene amine and collagen as previously described (Black and geyser, 1987) . FOr transplantation, cultures were rinsed twice in PBS, and then treated with 0.25 mg/ml collagensse for 15 min to release the neurons from the substratum. The floating mass of neurons, held together by a dense network of neurites, was then lifted from the culture dish, treated for 15 min with 0.25% trypsin and triturated into a single cell dispersion. Cell bodies were separated from remnants of the neurites by centrifugation, and were then plated into the chamber slides. For most experiments reported here, the transplanted neurons were maintained for 7-10 d before experimentation, although comparable results were obtained with cultures ranging in age from 3-14 d. This procedure resulted in moderate to low density cultures in which individual neurons generated readily distinguishable axons and dendrites.
Explant cultures were prepared using a procedure slightly modified from Peng et al., 1986 . Briefly, sympathetic ganglia were cut into 2-3 pieces/ ganglion, and placed into collagen-coated 35-mm culture dishes containing N2 medium supplemented with 1% human placental serum, 50 ng/ml nerve growth factor, and 0.6% methyl cellulose. Only 3-4 explants were grown per dish so that the axonal networks of neighboring explants did not overlap. Cultures were fed the next morning with the same medium without the methyl cellulose and serum, but containing 10/~M cytosine arabinoside, and were maintained for 7-10 d before experimentation. Explant cultures were a great advantage for electron microscopic analyses of axonal MTs because they consist of a centralized cell body mass that extends a dense halo of aligned axons, hundreds of which could be thin-sectioned simultaneously without contamination from cell bodies, dendrites, or nonneuronal cells (see Fig. 1 ).
Effects of Nocodazole on Axonal Microtubules
To quantify the effects of nocodazole on axonal MTs, explant cultures were treated for times ranging between 0 and 360 min with 2 #g/mI nocodazole (Aldrich Chemical Co., Milwaukee, WI), and then prepared for electron microscopy as previously described (Baas and Heidemann, 1986) . After embedment in resin, regions of the axonal halo were sectioned, viewed electron microscopically, and photographed. Total lengths of MT profiles were measured in the electron micrographs for each time point, and standardized to unit area of axoplasm. The latter was determined by trimming all empty space from the electron micrographs and weighing the micrographs as previously described . The MT mass remaining after drug tw~tment was then expressed as a function of the MT mass in control axons.
Immunofluorescence Analyses
Cultures on chamber slides were prepared for immunofluoresconce analyses using one of two extraction protocols, a harsher protocol for the moderate density cultures, and a milder protocol for the low density cultures. For the first, cultures were rinsed briefly in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl2 [pH 6.9]; Schliwa and van Blerkom, 1981) , and then extracted for 10 min with 1% Triton X-100 in PHEM also containing 10/~M taxol (gift from the National Cancer Institute) and 0.2 M NaC1 to remove free tubulin but stabilize existing MTs . For the second, cultures were rinsed briefly in PHEM, and extracted for 5 rain with 0.2% Triton X-100 in PHEM containing 10/~M taxol but no NaC1. For most experiments, extracted cultures were fixed by immersion in -20°C methanol for 10 min, rinsed with PBS, and incubated for 15 min
The Journal of Cell Biology, Volume 11 I, 1990 in a blocking solution containing 2% normal goat serum and 1% BSA. Cultures were then incubated with two primary antibodies (see below) simultaneously for 1 h at 35"C, rinsed extensively, incubated again for 15 min in blocking solution, incubated with two appropriate fluorescently tagged second antibodies simultaneously for 1 h at 35"C, and rinsed extensively gain. The slides were then removed from their chambers, mounted with a coverslip, and viewed with a Zeiss Axiovert 35 microscope using epifluorescence optics. In a limited number of experiments, extracted cultures were fixed with 0.5 % glutaraldehyde in PHEM for 10 rain at room temperature, rinsed with PBS, incubated with 2 mg/ml sodium borohydride for 15 rain, and then blocked and incubated with primary and secondary antibodies as described above. Comparable results were obtained with either fixation protocol. The primary antibodies were YL 1/2, a rat mAb specific for tyrosinated ct-tubulin (Kilmartin et al., 1982; Wheland et al., 1983) , purchased from Accurate Chemical & Scientific Corp. (Westbury, NY), and used at 1:100 dilution, and 6-11B-l, a mouse mAb specific for acetylated cc-tubulin (Piperno and Fuller, 1985) , generously provided by Dr. G. Piperno of the Rockefeller University, and used as the undiluted culture supernatant. In some experiments, a mouse general ¢-tubolin mAb (purchased from Amersham Corp., Arlington Heights, IL) was substituted for the 6-1113-1. The second antibodies were a fluorescein-conjugated goat anti-rat adsorbed against mouse Ig, and a Texas red-conjugated goat anti-mouse adsorbed against rat Ig, both purchased from Accurate Chemical & Scientific Corp. and used at 1:100 dilution.
Immunoelectron Microscopy
For immunoclectron microscopic analyses of axonal MTs, explant cultures were rinsed briefly in PHEM, extracted for 10 rain with 1% Triton X-100 in PHEM also containing 10 ttM taxol and 0.2 M NaCI, and then fixed by the addition of an equal volume of PHEM containing 1% glutaraldehyde (Folysciences Inc., Warrington, PA) directly to the extraction buffer. After 10 min of fixation, the cultures were rinsed in PHEM, then treated with 2 mg/mi sodium borohydride in PHEM for 15 min. Subsequent steps in our protocol were adapted directly from the standard protocol described by Geuens et al. (1986) . After sodium borohydride treatment, cultures were rinsed briefly in TBSI (10 mM "Iris, 140 mM NaCI, pH 7.6), incubated with a blocking solution containing 5% normal goat serum in TBSI, incubated overnight at 4"C with primary antibody (either YL 1/2 used at 1:200, or a mouse/3-tubulin mAb purchased from Amersham Corp., and used at 1:50) diluted in TBSI containing 1% normal goat serum, rinsed extensively in TBS2 (20 mM Tris, 140 mid NaCI, pH 8.2) containing 0.1% BSA, incubated for 3 h at 35"C with an appropriate second antibody conjugated to 5-nm gold particles (purchased from Janssen Life Sciences, Piscataway, NJ) diluted in TBS2 containing 0.1% BSA, and rinsed extensively in TBS2. The cultures were then fixed for 10 rain with 1% glutaraldehyde in 0.1 M ¢acodylate also containing 2 mg/ml tannic acid, rinsed in 0.1 M cacodylate, and postfixed in 2% OsO4 for 10 rain. Subsequent steps in electron microscopy were as previously described (Baas and Heidemann, 1986) . In some experiments, the epen block was stained for 1 h at 60°C with 1% toluidine blue in 1% borax, buffed with lens tissue, and then cow ered with a thin layer of immersion oil. This procedure, modified from Bartlett and Banker (1984) , enhanced the resolution of the axon as viewed by phase-contrast microscopy, and hence permitted us to readily identify the most distal regions of the extracted axons.
Results
Axons Contain Both Stable and Labile Microtubules
We previously reported that cultured sympathetic neurons contain two classes of MTs, termed stable and labile, that differ in their relative stability to MT depolymerizing drugs . For the present studies, we wished to determine whether or not both classes of MTs are present specifically in the axons of these neurons. To address this issue, we used morphological means to quantify the MT mass in axons as a function of time in 2/~g/ml nocodazole (see Materials and Methods). Somewhat to our surprise, it appeared that a relatively substantial portion of the MT mass depolymerized after even fairly short treatments with drug. Quantitative analyses reveal that the decrease in MT mass is biphasic (Fig. 2 d) , with "o48% of the MT mass depolymerizing with a hr2 of ,,o5 min, and the remaining polymer depolymerizing with a tla of ,~ 240 min. These results clearly indicate that axons contain both stable and labile MTs.
Stable and Labile Microtubules in the Axon Differ in Their ~-Tubulin Composition
We propose that stable and labile MTs in the axon exist as distinct domains on individual MTs rather than as separate populations of MTs. To test this hypothesis, we must be able to simultaneously visualize and distinguish stable and labile MTs, and thereby determine their spatial relationship relative to one another. In this section, we demonstrate that stable and labile MTs can be distinguished from one another. Then, in the following section, we use this information to show that stable and labile MTs exist as distinct domains on individual MTs.
Stable and labile MTs have been identified in many nonneuronal ceils on the basis of differences in their sensitivity to MTs depolymerizing drugs. These stable and labile MTs are also distinguishable on the basis of their u-tubulin composition; labile MTs are rich in tyrosinated t~-tubulin, whereas stable MTs are rich in ot-tubulin that has been posttranslationally detyrosinated and/or acetylated Piperno et al., 1987; Schulze et al., 1987; Kreis, 1987; Webster et al., 1987; Wheland and Weber, 1987; Gunderson et al., 1987; Bulinski et al., 1988) . If the same situation applies to the axon, then treatment of neurons with 2/~g/ml nocodazole for a time sufficient to completely depolymerize the labile MTs, while only minimally affecting the stable MTs, should substantially reduce or completely eliminate tyrosinated MTs from the axon while having little or no effect on detyrosinated and acetylated MTs. To test this prediction, control and drug-treated neurons were extracted to remove unassembled tubulin, and then double-stained for immunofluorescence analyses of tyrosinated and acetylated MTs (see Materials and Methods). Fig. 3 shows the results from these analyses. Each micrograph in the figure shows one or two cell bodies, each having Figure 3 . Double-label immunofluorescence analyses using the 6-1113-1 mAb to localize MTs rich in acetylated o~-tubulin (acetylated MTs), and the YL 1/2 mAb to localize MTs rich in tyrosinated c~-tubulin (tyrosinated MTs) in neurons that had been treated for 0, 30, 60, or 120 min with 2 ~,g/ml nocodazole (see Materials and Methods). Each micrograph shows one or two cell bodies, each having one or two dendrites that appear as relatively short processes that are broad at the base and taper with distance from the cell body. The remaining processes are axons. In control cultures, the staining patterns for tyrosinated and acetylated M'I~ are very similar, although lighter exposures reveal subtle differences in the staining patterns i n the cell body (these will be discussed in a subsequent publication). Nocodazole treatment had minimal effect on the staining pattern for acetylated MTs throughout the neuron. Drug treatment also had minimal effect on the staining for tyrosinated MTS in cell bodies and dendrites. However, tyrosinated MTs in the axon were very labile to drug treatment, as shown by the near absence of staining for tyrosinated MTs after as little as 30 min in the drug. Bar, 40 #m. one or two dendrites that appear as relatively short processes that are broad at the base and taper with distance from the cell body. Processes with this appearance were confirmed to be dendrites by their staining for MAP-2, a somatodendriticspecific marker (data not shown; see also Peng et al., 1986) . The remaining processes are axons, which typically run together in bundles containing varying numbers of axons. Because each neuron typically produces only a single axon (Bruckenstein and Higgins, 1988) , the vast majority of axons appearing in the fields shown in these micrographs originate from cell bodies located outside of the field. In control cultures, both tyrosinated and acetylated MTs are clearly present throughout the cell bodies, dendrites, and axons (Fig. 3,  a and b) . Treatment with 2 #g/ml nocodazole for 30, 60, or 120 min had no detectable effect on the staining pattern for acetylated ct-tubulin (compare Fig. 3 a to c, e, and g ). Similar results were obtained after an overnight (,M5-h) treatment with 2/xg/ml nocodazole, although the intensity of staining was reduced considerably compared to controls or to cultures that had undergone short-term nocodazole treatment (data not shown). Likewise, the staining pattern obtained using a mAb against total ot-tubulin was not detectably affected by nocodazole treatment, although the overall staining intensity was noticeably reduced at all times (30 min to overnight) examined (data not shown).
The staining pattern for tyrosinated MTs was dramatically affected by drug treatment, but in an unexpected manner. Treatment with 2 t~g/ml nocodazole for times ranging from 30 min to 15 h had minimal effect on the staining of the cell bodies and dendrites ( Fig. 3 and data not shown), and immunoelectron microscopic studies confirmed that the staining remaining in the somatodendritic compartment after 2 h of drug treatment was in the form of MTs (data not shown). In contrast, tyrosinated MTs in the axon were very drug-labile, largely disappearing within as little as 30 min of drug treatment (Fig. 3 , compare b with panels d, f, and h). Similar results were also obtained with neurons treated with 10 /~g/ml nocodazole. These results demonstrate that cell bodies and dendrites contain stable MTs, and that these MTs are rich in tyrosinated as well as acetylated ot-tubulin. In contrast, in axons, labile MTs are rich in tyrosinated c~-tubulin, whereas stable MTs contain little or no tyrosinated ot-tubulin, but instead are rich in acetylated c~-tubulin. Furthermore, because acetylated ot-tubulin in these neurons is also detyrosinated , stable MTs in the axon are also rich in detyrosinated ct-tubulin.
The above results suggest a close correspondence between the relative stability of axonal MTs and their tyrosination state. This was confirmed quantitatively by immunoelectron microscopic analyses of the distribution of tyrosinated o~-tubulin among axonal MTs. In these studies, control and drugtreated neurons were stained with the YL 1/2 mAb, which is specific for tyrosinated ct-tubulin, and an appropriate second antibody conjugated to 5-rim gold particles (see Materials and Methods). Roughly half of the MT profiles were labeled all along their length with gold particles, indicating that these profiles were rich in tyrosinated tx-tubulin, while roughly the other half were completely unlabeled, indicating that these profiles were deficient in tyrosinated ,v-tubulin, and hence rich in detyrosinated o~-tubulin (Fig. 4, b-e) . Typically tyrosinated MT profiles were densely and uniformly decorated with gold particles (see Fig. 4 b) , but a fraction of the MT profiles were noticeably less dense in their labeling (see Fig. 4 c) . The significance of this difference in the density of labeling is unknown. The presence of labeled and unlabeled profiles in our preparations cannot be attributed to differences in the ability of the 5-nm gold particles to penetrate different regions of the axonal mat for two reasons. First, densely labeled and completely unlabeled MT profiles were frequently observed side-by-side. Second, axons immunolabeled with a mAb to/~-tubulin known to label axonal MTs from other systems all along their length (Joshi and Cleveland, 1989 ) labeled all MT profiles in our preparation; most (i>90%) profiles labeled for/3-tubulin densely and uniformly, with only a very small number of profiles (x<10%) showing short regions of somewhat sparser labeling (Fig. 4 a) . Collectively, these observations indicate that the results obtained with the YL 1/2 mAb are not artifacts of penetration problems, but instead accurately reflect the existence of compositionally distinct MTs in the axon. Table I shows the results of quantitative analyses of the effects of nocodazole treatment on relative proportions of tyrosinated and detyrosinated MTs in the axon. In control cultures, 48 % of the MT mass was tyrosinated, while the remaining 52% was detyrosinated. After 15 min in nocodazole, roughly the amount of time needed to depolymerize the labile MTs without affecting the stable MTs (see Fig. 2 d) , only 7% of the MT mass was tyrosinated (Fig. 5) , thus decreasing the tyrosinated MT mass in the axon by ~85 %. After 30 min, 4% of the MT mass was tyrosinated, and after 60 min, no tyrosinated MTs remained. These data indicate that the tyrosinated MTs in the axon represent essentially the same subset of axonal MTs that are labile, and that the detyrosinated MTs in the axon represent the same subset of axonal MTs that are stable. Thus, tyrosinated ot-tubulin can be used as a reliable and highly specific marker that distinguishes the labile MTs from the stable MTs in the axon.
We note that the tyrosinated MT profiles remaining after drug treatment were entirely similar in appearance to the tyrosinated MT profiles in control cultures, and were not preferentially of either the more or less densely labeled type. The low levels of tyrosinated MTs in the axon remaining after drug treatment may reflect recently stabilized MTs that have not yet undergone a substantial degree of detyrosination. This interpretation is consistent with the temporal delay known to occur between MT stabilization and detyrosination (Khawaja et al., 1988) .
Stable and Labile Microtubules in the Axon Represent Distinct Domains on Individual Microtubules
If stable and labile MTs in the axon exist as distinct domains on individual MTs, then it should be possible to identify composite MTs in the axon that label for tyrosinated a-tubulin at one end but not at the other. Indeed, several examples of MT profiles labeled in this manner were observed (Fig.  6) . In all these cases, there was an abrupt transition between the labeled and unlabeled regions. The existence of these composite profiles indicates that at least some MTs in the axon consist of both a stable and a labile domain. We estimated the frequency of this type of MT taking into account the following considerations. The average length of an MT profile in our electron micrographs is ,~1/~m, while the average length of an entire MT in the axons of cultured neurons antibody, all MTs were labeled, and most were heavily labeled all along their length. On rare occasions, short segments of MTs were observed that were labeled somewhat more sparsely than the more typical heavily labeled profiles (arrow). (b-e) In samples stained with the YL 1/2 mAb, the vast majority of MT profiles either were labeled more or less uniformly all along their lengths, or were completely unlabeled. Some of the labeled profiles were less densely labeled than others; arrow (d) shows a less densely labeled profile situated above a more densely labeled profile. In addition, some MT profiles showed regions of dense labe$ing in direct continuity with unlabeled regions (e, straight arrow), e also shows an example of overlapping MTs decorated with gold particles in which it was not possible to determine which MT was specifically associated with the gold particles (curved arrow). Bar, 0.2 ltm. Axons treated for 0-60 min with 2/~g/ml nocodazole were intmunolabeled for tyrosinated ,',-tubulin with the mAb YL 1/2 (see Materials and Methods). For each time point, a total of ,'~1,000 t~m of MT profiles on randomly selected micrographs were scored as either labeled or unlabeled (see Results). A small number of profiles on some micrographs were not scored because of ambiguities resulting from closely spaced MT, one or more of which may have been labeled. The total lengths of the unlabeled and labeled profiles for each time point were then summed separately and recorded in the table.
is ~100 ~m (Bray and Bunge, 1981) . Thus, if all MTs in the axon consist of one stable domain and one labile domain, we would expect 1% of the profiles to show the transition region between these domains. In our studies, 21 of 5,000 MT profiles, or ,x,0.4%, showed both domains, suggesting that •40% of the MTs in the axon consist of both domains. The true proportion is probably higher in that we used very stringent criteria in scoring MT profiles consisting of both domains, eliminating several possible candidates because of neighboring MTs to which the gold particles might have alternatively been associated (Fig. 4 e) . Collectively, these observations indicate that a sizable proportion of MTs in the axon consist of a relatively stable domain in direct continuity with a more labile domain. Which end of the composite MT is stable and which end is labile? Explant cultures were especially useful in addressing this question because all of the axons from an explant culture grow in the same direction relative to the cell body mass (Fig. 1) . Thus, all of the MTs in a region of axons selected for thin-sectioning have the same polarity orientation, plus ends distal to the cell body mass, permitting ready determination of the plus and minus ends of each MT profile observed in our electron micrographs. In all 21 of the MT profiles we observed showing both stable and labile domains, the labile domain was always situated at the plus end of the stable domain (Fig. 6) .
Distribution of Stable and Labile Microtubules in the Axon
The immunofluorescence experiments shown in Fig. 3 indicate that stable and labile MTs are distributed throughout all regions of the axon discernable in moderate density cultures. However, the high degree of axonal bundling in these cultures precluded detailed analyses of the labeling patterns all along the length of the axon. Therefore, in a separate set of experiments, we analyzed the distribution of stable and labile MTs in the axons of lower density cultures. In these cultures, individual axons were minimally 2-mm in length, and stained for tyrosinated MTs all along their length. However, there was a clear diminution in the intensity of staining for tyrosina.ted MTs moving from the distal region of the axon into its main shaft. The most distal 25-75 #m of the axon stained brightly for tyrosinated MTs (Fig. 7) , with the intensity of staining gradually decreasing over the next 15-100 #m, reaching a relatively constant level of staining over the remaining portion of the axon (not shown). The same axons stained more or less uniformly for acetylated MTs all along their length, except at their most distal region contiguous with the growth cone, which stained poorly or not at all (Fig.  7) . Thus, the most distal region of the axon stained for tyrosinated MTs but not for acetylated MTs. The length of this distal region varied among different axons, ranging from ~10 #m (Fig. 7, c and e) to ,ol-2 #m (Fig. 7, d and f ) . These observations were confirmed by immunoelectron microscopic analy-•gure 5. Electron micrographs of MT profiles in axons that were treated for 15 min with 2 #g/ml nocodazole, and immunolabeled to reveal tyrosinated c~-tubulin, a is a typical region, showing many unlabeled but no labeled MT profiles, b is a much less typical region, showing many unlabeled MT profiles and one labeled profile. Bar, 0.2 #m. Figure 6 . Higher magnification electron micrographs revealing composite MT profiles that were labeled at one end for tyrosinated a-tubulin but not at the other end. In the fields shown, the axons were growing from the left to the right. Axonal MTs are oriented with their plus ends pointing away from the cell body and toward the axon tip (Heidemann et al., 1981) . Relative to the axonal fields illustrated in this figure, the cell bodies are situated toward the leR and the axon tips are situated toward the right (the cell bodies and axon tips are located outside the fields shown). Thus, the MTs in each field have their minus ends toward the leR anti their plus ends toward the right. Note that for all composite MT profiles, the regions labeled for tyrosinated ct-tubulin are toward the fight of the panels. Hence, the tyrosimted domains of composite MTs are situated at the plus ends of the detyrosinated domains. In addition, in all cases there is an abrupt transition between the labeled and unlabeled regions (arrows). a is a higher magnification photograph of the MT profiles shown in e of Fig. 4 . Bar, 0.1 #m.
ses; in three different axons examined, all of the MT profiles in the most distal 1-2 #In were labeled densely for tyrosihated ot-tubulin, while none of the MT profiles were unlabeled (Fig. 8) . Since tyrosinated MTs correspond to labile MTs in the axon, these results indicate that the distal region of the axon contains only labile MTs. Indeed, in five different axons treated with 2 #g/ml nocodazole for 15 rain, time sufficient to completely depolymerize labile MTs in the axon (Fig. 2) , the most distal 1-2 #m contained no MTs, differing from control axons that contained several MTs in their distal regions (Fig. 9 ). This contrasts with the situation in the main shaft of the axon, which contains roughly equal amounts of stable and labile> MTs (see above, Fig. 4, b-e) . Thus, both stable and labile MTs are present throughout the length of the ax0n, with the exception of its most distal region contiguous with the growth cone, which contains only labile MTs.
Discussion
Our studies reveal a strong correlation between the stability properties of axonal MTs and their tyrosination state. Roughly 48% of the MT mass in the axons of cultured sympathetic neurons is labile, depolymerizing with a tla of ,,o5 rain in the presence Of 2 #g/ml nocodazole, while the remaining 52 % of the MT mass is stable, depolymerizing with a t~ of ,,o 240 rain under these conditions (Fig. 2) . Immunofluorescence analyses indicate that labile MTs in the axon are rich in tyrosinated a-tubulin, whereas stable MTs contain little or no tyrosinated o~-tubulin, but instead are rich in acetylated and detyrosinated ot-tubulin (Fig. 3) . Quantitative analyses performed a t t h e immunoelectron microscopic level confirmed this result, indicating that ,,o85% of the tyrosinated M~i n the axon are depolymerized v~ithin 15 min of nocoda, Figure 7 . Phase-contrast (a and b) and immunofluorescence (c-f) images of the distal regions of two different axons double stained to reveal labile and stable MTs. Labile MTs were visualized with the mAb YL 1/2 against tyrosinated ¢-mbulin (c and d), while stable MTs were visualized with the mAb 6-11B-1 against acetylated c~-mbulin (e and f). Labile and stable MTs have similar distributions along the length of the axon, except in the most distal region, contiguous with the growth cone, which contains only labile MTs. Arrowheads mark sites where growth cones end. Unlabeled structures in b (above left arrowhead, and parallel to the axon in the middle) are collagen fibers. Bar, 30 ttm.
zole treatment, time sufficient to completely depolymerize the labile Mrs in the axon while only minimally affecting the stable MTs (Fig. 5, Table I ). These results demonstrate that tyrosinated cx-mbulin is a reliable and highly specific marker for labile MTs in the axon, and can be used to distinguish stable and labile MTs in microscopic analyses of the axon. We have taken advantage of these findings to simultaneously visualize and distinguish stable and labile MTs in the axon, and hence determine their distribution and spatial relationship relative to one another. 
Stable and Labile Microtubules Coexist along the Length of the A x o n
Qualitative immunofluorescence analyses localizing tyrosihated and acetylated MTs in a variety of neuronal systems indicate that the main shaft of the axon contains both stable and labile MTs, whereas the most distal region of the axon contiguous with the growth cone contains predominantly labile MTs (Figs. 3 and 7 ; see also Wheland and Weber, 1987; Robson and Burgoyne, 1988; Lim et al., 1989) . We have confirmed and expanded upon these results quantitatively by showing that similar levels of stable and labile MTs are present, and situated side-by-side with one another, along the main shaft of the axon (Figs. 2 and 4 , b-e), whereas exclusively labile MTs are present in the distal region of the axon contiguous with the growth cone (Figs. 8 and 9 ). Collectively, these results indicate that both stable and labile MTs coexist throughout the axon, except in its most distal region, which contains only labile MTs.
An initially surprising aspect of our data concerned the relative proportions of stable and labile MTs in the axon. Many studies on the properties of MTs in the axon have focused on the greater stability of axonal MTs compared to the rapidly turning-over MTs characteristic of proliferating cell types (Morris and Lasek, 1982; Black and Greene, 1982; Black et al., 1984 Black et al., , 1989 Brady et al., 1984; White et al., Figure 9 . Electron micrographs of the most distal 1-2 #m of the axon. a is an axon from a control culture, whereas b is an axon from a culture treated for 15 min with nocodazole to depolymeriz¢ labile MTs. MTs extend into the most distal 1-2 #m of the control axon, but are completely absent from the same region of the nocodazole-treated axon. Note that as expected (Joshi et al., 1986) , the drug-treated axon contains many more membranous profiles than the control axon. Bar, 0.2 #m. 1987 ). In addition to documenting the presence of high levels of stable MTs in the axons of cultured sympathetic neurons, our studies also indicate that a sizable proportion (~,48%) of the MT mass in these axons is labile, completely depolymerizing within the first 15 min in nocodazole (Fig.  2) . Because a high sensitivity to MT depolymerizing drugs generally indicates a rapid rate of subunit exchange, these results suggest that roughly half of the MT mass in the axon is very dynamic. Other studies also suggest substantial MT dynamics in axons. For example, 50% or more of the MT mass in diverse systems such as the squid giant axon (Morris and Lasek, 1984) , mature mammalian axons (Heidemann et al., 1984) , and the axons of cultured chick sensory neurons (Baas and Heidemann, 1986 ) rapidly disassemble in response to MT depolymerizing conditions. Also, haptenizedtubulin microinjected into PC12 cells and cultured neurons rapidly incorporates into the MTs of their axons Hirokawa, 1988, 1990) , suggesting relatively rapid subunit exchange between axonal MTs and the soluble tubulin pool. These findings suggest that MT dynamics comparable in degree to those observed in the axons of cultured sympathetic neurons may be a general feature of axons.
It has been proposed that local assembly of MTs in the axon and particularly at the axon tip contributes to the net addition of MTs to the axon during axon growth (Bamburg et al., 1986; Robson and Burgoyne, 1988; Mitchison and Kirschner, 1988) . This proposal derives from evidence suggesting that MTs in the distal region of the axon undergo rapid assembly/disassembly dynamics. As indicated above, our studies confirm such dynamics at the axon tip, and also demonstrate substantial assembly/disassembly dynamics throughout the length of the axon. Unfortunately, the demonstration of local MT dynamics in the axon does not directly address the contribution of local MT assembly to the net addition of MTs to the growing axon. While local assembly may increase the MT mass of the axon, it is also possible the assembly events are perfectly balanced by disassembly events within the MT array of the axon. New information will be required to resolve this issue.
A somewhat unexpected finding from our studies was that while tyrosinated ot-tubulin is a reliable marker for labile MTs in the axon, it is not a reliable marker for labile MTs in the somatodendritic compartment of the neuron. MTs in cell bodies and dendrites contain high levels of tyrosinated ot-tubulin, but as shown in Fig. 3 , some portion of these tyrosinated MTs are stable to drug treatments that completely depolymerize tyrosinated MTs in the axon. Thus, stable MTs are present in the somatodendritic compartment of the neuron as well as in the axon, but stable MTs in cell bodies and dendrites, as opposed to those in the axon, contain tyrosinated u-tubulin. Furthermore, based on the relative intensity of MT staining in control and drug-treated neurons, these stable but tyrosinated MTs represent a substantial fraction of the total MT mass present in cell bodies and dendrites.
Stable and Labile Microtubules Represent Distinct Domains on Individual Microtubules in the Axon
In addition to MT profiles that were either labeled for tyrosihated ot-tubulin all along their length or were completely unlabeled, immunoelectron microscopic analyses revealed a third type of MT profile that was densely labeled for tyrosinated ot-tubulin at one end, but was completely unlabeled at the other end. In all of these cases, the tyrosinated domain of these profiles was situated at the plus end of the detyrosinated domain, and there was an abrupt transition between the two domains (Fig. 6) . The existence of this third type of profile indicates that at least some MTs in the axon are composite, consisting of a dctyrosinated domain in direct continuity with a tyrosinated domain. Additional considerations provide information on the number of distinct tyrosinated and detyrosinated domains comprising these composite MTs. First, the fact that in any given section most MT profiles, regardless of their length, were either completely and uniformly labeled for tyrosinated o~-tubulin or were completely unlabeled suggests that axonal MTs have relatively infrequent transitions from one type of domain to the other. Indeed, even the longest MT profiles captured in our sections (•4 #m) contained no more than two domains. Second, the finding that tyrosinated MTs in the axon are depolymerized by *85% within the first 15 min in nocodazole, and are completely depolymerized by 1 h (Fig. 5 ; Table I ), indicates that only a very small portion of the tyrosinated MTs in the axon could be buried within the more stable detyrosinated domains. Finally, if a tyrosinated domain were flanked by two detyrosinated domains, or vice versa, we would expect to capture detyrosinated domains at the plus ends of tyrosinated domains equally as often as the reverse orientation. However, in all 21 composite profiles we observed, the tyrosinated domain was always situated at the plus end of the detyrosinated domain. Collectively, these observations suggest that composite MTs in the axon consist of one tyrosinated domain situated toward the plus end of the MT, and one detyrosinated domain situated toward the minus end of the MT. Furthermore, because tyrosinated and detyrosinated MTs in the axon correspond to labile and stable MTs respectively, we conclude that composite MTs consist of a single labile domain in direct continuity with a single stable domain, with the labile domain always situated at the plus end of the stable domain.
We tentatively estimate that 40% of the MTs in the axon are composite. This estimate is based on the observed frequency of MT profiles showing a transition region between the labile and stable domains, on the assumption that MTs in the axons studied average ,x,100 #m in length, and on the probability of capturing the transition region between the labile and stable domains of individual MTs in our sections (see Results). Because very strict criteria were used in scoring MT profiles consisting of both domains, the actual proportion of composite MTs in the axon may be much higher (see Results). Thus, the results of our studies clearly indicate that a sizable proportion of MTs in the axon are composite, consisting of one stable domain in direct continuity with one labile domain.
Both the extreme drug sensitivity of the labile domains and the abrupt transition in tyrosination state between the stable and labile domains on composite MTs suggests that the labile domains turnover very rapidly, more rapidly than the rates at which they can be detyrosinated. Conversely, the relative insensitivity of the stable domains to drug-induced depolymerization and their high levels of detyrosinated and acetylated ot-tubulin indicate that these MTs turnover quite slowly relative to the labile domains. The direct continuity of the rapidly turning over labile domains with the slowly turning Figure 10 . Schematic depicting the spatial organization of labile and stable MTs in the axon. The plus ends of the MTs are directed away from the cell body, while the minus ends of the MTs are directed toward the cell body. A sizable proportion of the MTs in the axon consist of two domains, a relatively stable domain at the minus end, and a more labile domain at the plus end. In addition, the axon may contain some MTs that are entirely stable (indicated with question marks). These MTs may be entirely stable because they are capped against assembly at both ends, or because their labile domains have recently undergone catastrophic disassembly (see text). The existence of entirely labile MTs in the axon is doubtful in that new MT assembly in the axon is apparently restricted to elongation from preexisting MTs (see text). Both labile and stable MT domains are present all along the length of the axon, except in the most distal region of the axon contiguous with the growth cone, into which extend only the labile domains of MTs originating more proximally in the axon. The schematic also depicts MTs in the cell body as consisting of both domains. At present, this is hypothetical; we have identified stable and labile MTs in the cell body, but have not explored their spatial relationship relative to one another.
over stable domains thus indicates that the labile MTs assemble directly from the stable MTs. It therefore follows that the plus ends of stable MTs are assembly competent, and nucleate MT assembly in the axon. Recent studies on MT dynamics in isolated segments of the axon (Baas and Heidemann, 1986) further suggest that stable MTs represent the only long-lived templates for MT assembly in the axon. In these studies, isolated segments of the axon were treated with varying doses of nocodazole, rinsed free of the drug, and then evaluated for MT reassembly by electron microscopy. MT reassembly occurred rapidly during recovery from drug treatments that depleted labile but not stable MTs, but did not occur during recovery from drug treatments that depleted the stable as well as the labile MTs. These results indicate that MT assembly in the axon occurs by elongation from preexisting MTs rather than by self-association of tubulin subunits into new MTs or by elongation from non-MT nucleating structures. Thus, stable MTs are not only assembly competent, but also apparently represent the preferred and perhaps exclusive templates for local MT dynamics in the axon. The mechanisms that underlie the rapid turnover of labile MTs in the axon are a matter of speculation at present. In many cell types, the rapid turnover of MTs can be explained by the dynamic instability model (for review, see Kirschner and Mitchison, 1986) . Assuming that dynamic instability accounts for aspects of MT turnover in the axon (Mitchison and Kirschner, 1988) , it seems reasonable to suggest that the labile domains of axonal MTs may be dynamically unstable, undergoing rapid phases of elongation from the plus ends of stable MTs, followed by catastrophic disassembly of the labile MTs either partially or completely back to the plus ends of the stable domains. In this view, the stable MTs not only serve as templates for local MT dynamics in the axon, but also rescue catastrophic disassembly of the labile domains and thereby ensure the continued existence of the MTs. Because axons apparently lack the ability to generate MTs de novo (Baas and Heidemann, 1986) , this rescue function may be particularly important for maintaining the MT array of the axon. Fig. 10 schematically summarizes the contribution of the present study to current understanding of the organization of MTs in the axon. Previous studies have shown that axonal MTs do not radiate from a single, centrally situated nucleating structure (Lyser, 1968; Sharp et al., 1982; Stevens et al., 1988; Okabe and Hirokawa, 1988) , but rather start and stop at multiple sites along the length of the axon (Chalfie and Thompson, 1979; Bray and Bunge, 1981; Tsukita and Ishikawa, 1981) . Our studies suggest that most MTs in the axon are composite, consisting of a labile domain in direct continuity with the plus end of a stable domain. Entirely stable MTs are depicted with question marks; while we have no direct evidence that such MTs exist, they may in principle be generated from composite MTs after complete catastrophic disassembly of their labile domains. No entirely labile MTs are depicted because labile MTs are proposed to elongate specifically from the plus ends of stable MTs (see above). Furthermore, any spontaneously formed labile MTs would be at a kinetic disadvantage compared to composite MTs, and so would be expected to depolymerize in favor of elongation from composite MTs (Kirschner and Mitchison, 1986) . The plus ends of stable MTs are distributed all along the length of the axon, indicating that stable templates for local MT dynamics exist throughout the axon. Labile MTs that grow from these templates will have the same polarity orientation as the templates themselves, which is plus end distal to the cell body (Heidemann et al., 1984) . Furthermore, because assembly occurs preferentially from the plus ends of the stable MTs, MT assembly in the axon will occur in a direction away from the call body toward the axon tip. Thus, stable MTs organize the assembly of MTs in a common direction in the axon, and with a common polarity orientation. These observations indicate-that stable MTs spatially organize MT assembly in the axon in much the same way that traditional MT nucleating structures such as the centrosome organize MT assembly in other cell types. However, unlike the centrosome, which organizes MT assembly from a discrete, often centralized location in the cell, stable MTs in the axon organize assembly from multiple sites that are widely distributed along the length of the axon.
Stable Microtubules Organize Microtubule Assembly in the Axon
The preceding discussion has emphasized the potential role of stable MTs as nucleating structures for local MT assembly/disassembly dynamics in the axon. In particular, we have suggested that stable MTs may be the only long-lived templates for MT assembly in the axon, and, as such, they will help ensure the continued existence of the axonal MT array. An issue not addressed by the present studies but of obvious relevance concerns the generation of the stable MT array of the axon. This issue encompasses many questions, including how and where stable MTs are generated, and how stable MTs obtain their uniformly plus-end-distal polarity orientation. Studies are in progress to begin answering these questions.
